镰状细胞特质与因子V Leiden携带者静脉血栓栓塞风险的家系独立性比较
基于23andMe研究队列4 184 082名参与者,按3个遗传祖先组(欧洲、拉丁、非洲)Meta分析计算镰状细胞特质(SCT)与静脉血栓栓塞(VTE)的关联,并与因子V Leiden(FVL)比较;SCT携带者VTE风险为1.45倍,以肺栓塞为主,而FVL携带者VTE风险为3.30倍,以孤立性深静脉血栓为主。
要点
- SCT携带者VTE风险较非携带者升高1.45倍(95%CI 1.32-1.60)。
- SCT携带者肺栓塞风险升高(OR 1.95),孤立性DVT风险无显著升高(OR 1.04,95%CI 0.90-1.21)。
- FVL携带者VTE风险为3.30倍,孤立性DVT风险(OR 3.59)高于肺栓塞(OR 2.72)。
核心结论
- 在该大型多样化队列中,SCT个体VTE风险较非携带者升高,且独立于种族或遗传祖先。
- SCT的VTE风险低于FVL,但SCT以肺栓塞为主,与FVL以孤立性DVT为主相反。
研究设计与样本
- 利用23andMe研究队列共4 184 082名参与者,按3个遗传祖先组(欧洲n=3 183 142、拉丁n=597 539、非洲n=202 281)进行Meta分析。
- 二次全队列分析额外纳入东亚(n=159 863)与南亚(n=41 257)两组。
- 全队列中94 323人(2.25%)报告有VTE史。
主要发现
- Meta分析中,SCT携带者VTE风险为非携带者的1.45倍(95%CI 1.32-1.60),与全队列估计相似。
- SCT携带者肺栓塞风险OR 1.95(95%CI 1.72-2.20),孤立性DVT风险OR 1.04(95%CI 0.90-1.21)。
- FVL携带者VTE风险为非携带者的3.30倍(95%CI 3.24-3.37),孤立性DVT风险OR 3.59(95%CI 3.51-3.68),肺栓塞风险OR 2.72(95%CI 2.64-2.81)。
关键数值与推荐
- SCT携带者VTE风险OR 1.45(95%CI 1.32-1.60)。
- SCT携带者肺栓塞OR 1.95(95%CI 1.72-2.20),孤立性DVT OR 1.04(95%CI 0.90-1.21)。
- FVL携带者VTE风险OR 3.30(95%CI 3.24-3.37),孤立性DVT OR 3.59(95%CI 3.51-3.68),肺栓塞OR 2.72(95%CI 2.64-2.81)。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Sickle cell trait (SCT) is a risk factor for venous thromboembolism (VTE). Prior studies investigating the association between SCT and VTE have been performed nearly exclusively in Black populations. However, race-based research can contribute to systemic racism in medicine. We leveraged data from the 23andMe research cohort (4 184 082 participants) to calculate the ancestry-independent risk of VTE associated with SCT as well as comparative risk estimates for heterozygous factor V Leiden (FVL). Odds ratios (ORs) were calculated using a meta-analysis of 3 genetic ancestry groups (European [n = 3 183 142], Latine [n = 597 539], and African [n = 202 281]) and a secondary full-cohort analysis including 2 additional groups (East Asian [n = 159 863] and South Asian [n = 41 257]). Among the full cohort, 94 323 participants (2.25%) reported a history of VTE. On meta-analysis, individuals with SCT had a 1.45-fold (confidence interval [CI], 1.32-1.60) increased risk of VTE compared with SCT noncarriers, which was similar to the full-cohort estimate. The risk of pulmonary embolism (PE) in SCT (OR, 1.95; CI, 1.72-2.20) was higher than that of isolated deep venous thrombosis (DVT; OR, 1.04; CI, 0.90-1.21). FVL carriers had 3.30-fold (CI, 3.24-3.37) increased risk of VTE compared with FVL noncarriers, with a higher risk of isolated DVT (OR, 3.59; CI, 3.51-3.68) than PE (OR, 2.72; CI, 2.64-2.81). In this large, diverse cohort, the risk of VTE was increased among individuals with SCT compared with those without, independent of race or genetic ancestry. The risk of VTE with SCT was lower than that observed in FVL; however, the pattern of VTE in SCT was PE predominant, which is the opposite to that observed in FVL.
引用
- Lin KH, Granka JM, Shastri AJ, et al. Ancestry-independent risk of venous thromboembolism in individuals with sickle cell trait vs factor V Leiden. Blood Adv. 2024. PMID: 39255335. doi:10.1182/bloodadvances.2024014252
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。